Carrier-Free Self-Assembled Nanoparticles for Triple-Amplified Tumor Chemodynamic Therapy and Cuproptosis Induction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40326191.
- Also identified by DOI 10.1002/adhm.202501507.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemodynamic therapy (CDT) holds great promise in cancer treatment, whereas its efficacy is severely compromised by the low concentration of endogenous hydrogen peroxide(H<sub>2</sub>O<sub>2</sub>), insufficient exogenous catalytic ions, and the presence of high levels of cellular glutathione (GSH). Herein, a dissociable, tumor cell membrane-camouflaged carrier-free nanoparticle is developed through the molecular interaction of copper ions (Cu<sup>2+</sup>), dequalinium (DQ), and β-Lapachone (β-Lap). Upon homotypic tumor targeting, the system releases Cu<sup>2+</sup> (exogenous catalytic ions), β-Lap (H<sub>2</sub>O<sub>2</sub> donor), and DQ (GSH scavenger), achieving triple amplification of CDT efficacy. Concurrently, the intracellular accumulation of Cu<sup>2+</sup> induces cuproptosis, thereby synergistically augmenting CDT efficacy and strikingly restraining tumor growth. Overall, the integration of Cu<sup>2+</sup> supplementation, H<sub>2</sub>O<sub>2</sub> self-supplying, and GSH depletion offers a promising avenue for improving cancer treatment outcomes and paves a new way for multimodal cancer therapy.
Medical subject headings
- Copper
- Nanoparticles
- Neoplasms
- Antineoplastic Agents